Skip to main content

CompuGroup Medical acquires French firm Epsilog

German ehealth software firm CompuGroup Medical SE has acquired French primary care records specialist Epsilog for EUR 72 million. The acquisition expands CGM’s position in France and boosts its presence in the primary care software market.

Epsilog markets its range of Vega ambulatory primary care records systems, which are aimed principally at independent community healthcare practitioners such as private nurses, physiotherapists, speech and language therapists, and orthoptists.

Vega software is designed for use on tablets, smartphones and laptops, and incorporates software to integrate Vitale smart card readers, allowing invoicing and settlement of care covered by the French national health insurance system.

The acquisition of Epsilog supports CGM’s push into primary care health apps and primary care telemedicine. In early 2019, CGM launched its Clickdoc platform and health apps. Clickdoc allows patients to use their phones to search for primary care doctors and other health professionals, make bookings, and have teleconsultations instead of having to attend a practice office.

CGM has acquired 100 percent of the shareholdings of Epsilog from Hevanance and Goodwill Systems. In 2018, Epsilog posted earnings before interest, tax and depreciation (Ebitda) of around EUR 5 million.

Headquartered in Koblenz, Germany, CGM operates in 19 countries, with a strong presence in Austria, Italy, Spain, Sweden, Czech Republic, and France. The company generated revenues of EUR 717 in 2018.

References:
Labels:

Comments

Post a Comment

Popular posts from this blog

Austria develops Smart Covid-19 Test

Austrian low power sensor firm ams AG has received funding from two Austrian Government ministries to develop a smart device to provide accurate testing for Covid-19. The hand held device is directly connected to a "medical data cloud", does not require a laboratory, and can deliver accurate test results within 15 minutes. The two Austrian Government departments funding the new device are the Federal Ministry of Climate Action, Environment, Energy, Mobility, Innovation and Technology (BMK), and the Federal Ministry for Digital and Economic Affairs (BMDW). ams has used the funds to develop a connected, smart version of a lateral flow test (LFT) device. Lateral flow tests are a standard approach for rapid point of care (PoC) testing. LFTs, which are usually analogue devices, are typically intuitive and easy to use, and are subject to strict regulatory requirements. A pregnancy strip test is a typical example of an analogue LFT device. The challenge for ams was threefold: to cre...
Post a Comment
Read more

Heidelberg develops Unsupervised AI for motor disease

Researchers at the universities of Heidelberg in Germany, and Zurich in Switzerland have developed an AI model to detect human motor impairments and determine underlying diseases. The new software is also a test for how effective unsupervised AI behaviour analysis can be in discovering and determining complex disease states. Conventional supervised instrumented movement analysis is time-consuming, potentially subjective, and cost-intensive. It requires prior knowledge of behaviours of interest, and typically a large amount of video frame annotation. There is scope for human annotator bias, with different annotators focusing on different behaviours, while ignoring or minimising others. The researchers have developed uBAM ("unsupervised Behaviour Analysis and Magnification using Deep Learning"). This is a fully automatic, unsupervised diagnostic support system for behaviour analysis. The new system can extract and classify behaviour automatically, with the ability to compar...
Post a Comment
Read more